Frank Witney - Apr 4, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Director
Signature
/s/ Frank Witney by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/6/2022, 06:35 PM
Previous filing
Jun 17, 2021
Next filing
May 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock +Grant/Award $0 +15,852 $0.00 15,852 Apr 4, 2022 Direct F1
holding LAB Common Stock 4,225 Apr 4, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Stock Option (Right to Buy) +Grant/Award $0 +23,401 $0.00 23,401 Apr 4, 2022 Common Stock 23,401 $3.99 Direct F3

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.
F2 Shares held indirectly by First Amended and Restated Revocable Trust Agreement For The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
F3 The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.